ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
135,488,140
Total 13F shares
67,961,552
Share change
+819,504
Total reported value
$4,505,834,422
Put/Call ratio
53%
Price per share
$66.30
Number of holders
297
Value change
+$55,872,415
Number of buys
134
Number of sells
139

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q4 2021

As of 31 Dec 2021, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 297 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,961,552 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, JOHNSON & JOHNSON, JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and FMR LLC. This page lists 298 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
282
Q4 2021 holders
297
Holder diff
15
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.